GEN Exclusives

More »

GEN News Highlights

More »
Apr 9, 2008

Intradigm Licenses siRNA IP from UMass Medical

  • Intradigm has licensed intellectual property covering certain efficacy-enhancing structural elements of siRNA from the University of Massachusetts Medical School.

    The licensed technology will allow Intradigm to incorporate novel siRNA sequences into its RNAi delivery systems. This IP includes parameters for the structural modifications for siRNAs including the Zamore Design Rules that improve the potency and efficacy of RNAi therapeutics, according to the company.



Jobs

GEN Jobs powered by HireLifeScience.com connects you directly to employers in pharma, biotech, and the life sciences. View 40 to 50 fresh job postings daily or search for employment opportunities including those in R&D, clinical research, QA/QC, biomanufacturing, and regulatory affairs.
 Searching...
More »

GEN Poll

More » Poll Results »

Should “Special K” Get Special Treatment?

In the near term, what is the best way to use ketamine in treating depression?